Table 2

Haemodynamic measurements and echocardiographic data after PMV of the entire patient population and after stratification according to the cardiovascular mortality

Postprocedural valuesOverall population
(n=427)
Survivors
(n=378)
Deceased (cardiovascular death)
(n=41)
p Value
Echocardiographic data*
 Mitral valve area (cm2)1.57±0.311.59±0.301.29±0.290.001
 Moderate MR (n (%))103 (24)87 (23)15 (37)0.017
 Severe MR (n (%))23 (5)21 (5)2 (5)0.746
 Peak gradient (mm Hg)14.4±5.413.9±5.117.9±6.10.001
 Mean gradient (mm Hg)6.6±2.66.4±2.57.9±2.90.002
 LAV index (mL/m2)61.2±30.559.9±29.373.9±37.30.035
 SPAP (mm Hg)44.1±15.842.3±14.161.0±18.7<0.001
  RVFAC (%)48.5±9.849.2±9.442.1±11.10.001
 Moderate or severe TR (n (%))86 (20)65 (17)20 (49)<0.001
Haemodynamic data
 LA pressure (mm Hg)17.7±6.517.6±6.418.2±7.20.698
 Mean PAP (mm Hg)31.1±11.830.2±11.338.3±14.10.002
 Cardiac index (L/min/m2)2.8±0.82.9±0.82.3±0.60.024
 TPG (mm Hg)†11 (7/17)11 (7/16.3)21 (7/26.5)0.049
 PVR (wood unit)2.6 (1.5/4.2)2.5 (1.5/4.1)2.8 (2.1/5.90.122
  • Data are expressed as the mean value±SD, median (IQR) or absolute numbers (percentage).

  • *Twenty four hours after PMV.

  • †In those patients who developed procedural complications, especially severe mitral regurgitation, these parameters were excluded from the analysis.

  • LA, left atrium; LAV, left atrial volume; MR, mitral regurgitation; PAP, pulmonary artery pressure; PMV, percutaneous mitral valvuloplasty; PVR, pulmonary vascular resistance; RVFAC, right ventricular fractional area change; SPAP, systolic pulmonary artery pressure; TPG, transpulmonary pressure gradient; TR, tricuspid regurgitation.